Summary:
- The article analyzes the historical decline of South Africa’s domestic vaccine manufacturing capabilities compared to Botswana’s strategic investment in maintaining sovereign production capacity.
- It explores the intersection of industrial policy, public health infrastructure, and the geopolitical challenges of maintaining national self-reliance in the biotechnology and pharmaceutical sectors.